Dataset from A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis

Name: Dataset from A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Creator: 暂无描述
License: 暂无描述

NIAID Data Ecosystem2026-05-10 收录

下载链接：

https://doi.org/10.25934/PR00011868

下载链接

链接失效反馈

官方服务：

资源简介：

This open-label study will evaluate the long-term efficacy and safety of baricitinib in adult participants with moderate to severe atopic dermatitis (AD).

创建时间：

2025-10-20